Accanto Partners is a venture capital firm that primarily invests selectively in promising tech startups, often in their first professional financing rounds. Their strategy involves providing thoughtful support to founders as they grow their companies, leveraging an entrepreneurial viewpoint, and participating in subsequent funding rounds.
50% of their portfolio is in Healthcare. Their most common stage is series-a (50% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Adaptilens, Inc. | Series A | $17.5M | Apr 2024 |
 Catalant Technologies | Series D | $41M | Jun 2017 |
Top Co-Investors
Pillar VC1 shared
General Catalyst1 shared
Greylock Partners1 shared
Highland Capital Partners1 shared
GE Ventures1 shared
Last updated: 4 May 2026